Carlos Alvear Lopez · 66-41 · MEXICO
For Carlos Alvear Lopez, import alert is 66-41; country is MEXICO; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is Diabetless Plus (powder or capsule) | Diabetless Plus (powder or capsule); product code is 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/17/2022; address is Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO, verified against its source on 2026-10-01.
- Firm
- Carlos Alvear Lopez verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- MEXICO verified
- Address
- Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO verified
- Date published
- 06/17/2022 verified
- Product code
- 54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- Diabetless Plus (powder or capsule) | Diabetless Plus (powder or capsule) each item verified
- FDA notes
- The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. each item verified
What the source says
Carlos Alvear Lopez Date Published : 06/17/2022 Domicilio Conocido S/N , Jalmolonga Malinalco, Mexico MEXICO
— accessdata.fda.gov, retrieved 2026-09-15
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
54 - - - -- Vitamins/Minerals (Human/Animal); Proteins/Unconv Dietary Supp (Human) Date Published: 06/17/2022 Desc: Diabetless Plus (powder or capsule) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/17/2022 Desc: Diabetless Plus (powder or capsule) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘Diabetless’.
— all from accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html